Clinical Advisory Board

Our Clinical Advisory Board, chaired by Frank Chinegwundoh MBE, consists of specialists who advise us on our clinical  agenda. They are:

Prof Frank Chinegwundoh MBE  MBBS MS MML FRCS(Eng) FRCS(Ed) FRCS(Urol) FEBU

I completed my medical degree at St George’s University Hospital, London.  After 12 years of training in various establishments in the UK and USA, I was appointed as a Consultant Urological Surgeon in 1996.  Along the way I obtained a Master of Surgery degree by thesis. As a consultant I have undertaken further training in Seattle to be able to offer low dose rate brachytherapy at Barts Health NHS Trust.

In 2008 I received a National award for clinical excellence, which was renewed in 2013.  I completed my Masters in Medical Law (MML) from Glasgow University in 2010.

I was the first to demonstrate that black men in the UK have a three-fold risk of prostate cancer (2006). My main research interest is in prostate cancer and ethnicity, which has led to international lecturing opportunities.

I am on the selection panel for medical students at Barts and for postgraduates examine MD(research) theses.  Other commitments include serving on various Department of Health (DH) committees including the prostate cancer advisory group, national cancer equalities initiative, bowel cancer screening advisory committee amongst others and was a member of the  cancer reform strategy board.

Since 1998 I have been executive chairman of the charity Cancer Black Care.  In 2013 my services to the NHS were recognized with an MBE and in 2015 I was confirmed as Honorary Visiting Professor at City University London, in the School of Health Sciences.


Steve Allen, Tackle Patient Representative

I was diagnosed with prostate cancer at the age of 59.  I could have been diagnosed earlier, but I had studiously ignored my classic urinary symptoms for nearly 2 years.  My PSA had consistently been at the upper limit of normal for around 6 years before I decided to go and get some advice.  It came as a great shock that, instead of my expected diagnosis of benign prostate enlargement, I was told I had a cancer.  I felt extremely guilty that I had potentially left things until it was too late.  My decision to undergo surgery was a ‘no brainer’ – “I have a cancer, let’s just get rid of it!”  The long term outcome has been good in that my PSA levels remain consistently low.  However I have been plagued by virtual total incontinence of urine and severe sexual dysfunction.  The former has been helped by surgery; the latter has improved somewhat with time.

To my great embarrassment, I am also a retired doctor.  At the time of my diagnosis I was a consultant anaesthetist who had worked alongside the urologists in my hospital for over 25 years.  I, indeed, should have known better but I can understand why many men at times are reticent to go and seek help.  Being a doctor obviously helped as I could understand the ‘long medical words’ but in no way prepared me for the experience of being a patient with prostate cancer.

By today’s standards I have probably been over-treated.  To be regretful or angry about this is totally non-productive.  I am now closely involved as a volunteer with Tackle and with Prostate Cancer UK.  I see working with both charities as being a symbiotic relationship and certainly not competitive.  Both have the same objectives for men and their families affected by prostate cancer. Through my work with them I have gained a huge amount of knowledge and understanding from the experiences that many people have shared with me over the past years.

A year ago I was asked to take on a role as a patient representative for Tackle, including involvement with such national bodies as NICE and the National Prostate Cancer Audit.  It can, at times, be a daunting task.  At one end of the spectrum is a need to understand the often complex and frustrating ways in which government bodies and the pharmaceutical industry work.  However, my most important objective will always be to ensure that the voice of the patient is both heard and taken notice of.  I may not always be able to speak from personal involvement concerning a particular drug or treatment but can always reflect the experience and opinions of those men with whom I have already met and will continue to meet in the future.  It is a role which carries a significant degree of responsibility but also one which can result in huge rewards for the people I try to represent.


Chris Booth MBBS, FRCS

I qualified from St Bartholomew’s Hospital in 1969 and trained in Urology at the Institute of Urology, the Middlesex Hospital and Dublin, winning the BAUS Travelling Fellowship for clinical research.

From 1984-2006 I was lead urologist at Colchester General Hospital, achieving Regional Urology Cancer Centre accreditation in 2006.  During this time the department was heavily involved in trial work, clinical research and service redesign, becoming a DoH pilot site for the Cancer Services Collaborative, Action On Urology and the Informed Decision Making programmes.  These led to my drafting the urology chapters for the DoH’s reports on Shifting Care Closer to Home and World Class Commissioning.

Since 2006 I have worked independently, providing urological consultancy in the East of England, for Tower Hamlets PCT and for the Greater Manchester Clinical Assessment & Treatment Service.  I have just established the NHS Alliance’s Specialist Urology Group, am a Director of Healthwatch Essex and the Clinical Director for the Men’s Health Charity CHAPS.

I have, on occasion, been a Visiting Professor at Essex University, an Honorary Professor at City University and sometimes play golf.


Prof Nick James BSc (Hons) MBBS PhD FRCP FRCR

I am Founding Director of the University of Warwick Cancer Research Centre and Consultant in Clinical Oncology at the Queen Elizabeth Hospital Birmingham. I was previously Professor of Clinical Oncology at the University of Birmingham until my move to Warwick in 2013. I qualified in 1983 from St Bartholomew’s with the principal class medical prize and a First in Immunology. I undertook postgraduate training in London, Brussels and Tokyo as well as a PhD at Imperial College, London.

I co-founded the leading website CancerHelp UK in 1994. The website was one of the first to focus exclusively on patient information and was underpinned by a programme of educational research. It featured the first searchable database of clinical trials for patients seeking to enter a study. In 2002 it became the main patient resource on the Cancer Research UK website until being recently absorbed into their main site.

In the prostate cancer field, I led the first UK trial of gene therapy in prostate cancer and was UK chief investigator on the TAX327, which led to the licensing of docetaxel for prostate cancer. I have subsequently led a range of trials in prostate cancer most notably the STAMPEDE trial. This novel multi-arm multi-stage trial has formed a platform for testing, in parallel, a range of different therapies and has now recruited over 7000 men. The recent analysis of the docetaxel data from this study has demonstrated that use of docetaxel at diagnosis of advanced disease improves overall survival by over 20%.

In the bladder cancer field, I have led a series of trials of chemoradiotherapy for bladder cancer culminating in the phase III BC2001 trial, published in the New England Journal of Medicine in 2012 with an accompanying editorial describing the work as “ground-breaking” and “practice changing”.


Prof Stephen Langley MBBS(Hons) MS FRCS Urol

I am a Consultant Urological Surgeon at the RoyalSurreyCountyHospital and the St Luke’s Cancer Centre in Guildford.  I became a Consultant in 1998 and then after 6 years was appointed as Professor of Urology at the PostGraduate MedicalSchool of the University of Surrey, where I co-lead a major research programme in the field of prostate cancer.

I was educated at St Paul’s School London before studying medicine at St Bartholomew’s Medical School, London. I graduated with honours in 1988 and then began my surgical training.  In 1996 I passed my Specialist Consultant exams in Urology in which I was awarded the Keith Yates Gold medal for outstanding performance.

I have an international reputation as an expert in the diagnosis and treatment of early prostate cancer. In 1999 I pioneered the treatment of early prostate cancer by brachytherapy in the UK. This technique uses tiny radioactive seeds implanted into the prostate gland which treats the prostate cancer sparing the surrounding tissue.  To date I and my large team have successfully treated over 3000 men with this treatment.  The excellent clinical results have been widely published and presented.

In 2012 I published and presented the technique of 4D Brachytherapy, a novel method to perform prostate brachytherapy using both stranded and loose seeds in a one-stage procedure with real-time dosimetry.  This technique delivers an improved radiation dose to the prostate whilst reducing the side effects compared to earlier techniques. 4D Brachytherapy is quick to perform, reducing the anaesthetic time and allowing patients a quicker recovery.

My passion to improve the care for prostate cancer patients led me in 2003 to invent the technique of prostate template biopsy. This new method allows the surgeon to diagnose and monitor cancerous changes within the prostate in a more detailed and specific way. This technique, developed in Guildford, has been NICE approved and is now used throughout Europe.

I am a pioneering clinician and in recent years have trained as a robotic surgeon.  I use a Da Vinci robot to surgically remove cancerous prostate glands from patients as another tool in my armamentarium to treat prostate cancer patients.

I am the Chairman of the UK Prostate Brachytherapy Advisory Group and sit on the Department of Health’s Prostate Cancer Advisory Group, influencing national policy.  In 2005 I received Karl Stortz Golden Cystoscope awarded from the British Association of Urological Surgeons for an outstanding contribution to British Urology.  In 2013 I received a Silver Clinical Excellence award.  I have recently spearheaded a successful campaign to raise £4m from Charitable and NHS funds to build a prestigious new Centre of Urology at the RoyalSurreyHospital due for completion in 2017.

I am married with a daughter.  My interests outside of medicine include rugby, boating and sailing. I am a qualified Yachtmaster and like to spend most of my spare time afloat in the Caribbean and Mediterranean waters.


Prof Heather Payne MBBS, FRCP, FRCR

I am a Consultant in Clinical Oncology at University College Hospital, London. I trained at St Mary's Hospital London and after qualifying spent time working in general medicine both in London and also in Haiti where conventional medicine was mixed with voodoo practices.

I returned to London to train as a Clinical Oncologist and during this time developed an interest in urological oncology. I now have a busy practice in a teaching hospital where I work within a multidisciplinary team. I am actively involved in clinical research in all these therapeutic areas and have pioneered a programme of High Dose Rate Brachytherapy for prostate cancer.

My current research interests also include hormone therapy, sensitisation of hormones and radiotherapy, predictive indices for bowel toxicity with radiotherapy, chemotherapy and quality of life and decision-making for men with prostate cancer.

I am Principal Investigator in a number of international multi-centre and local studies. I am a trustee of the Prostate Cancer Research Centre and the chairman of the British Uro-oncology Group (BUG). I am the oncology lead for the National Prostate Cancer Audit.



GP, Backwell & Nailsea Medical Group with specialist interest in Men’s Health and Urology

I trained in Urology in Taunton and became a Member of the Royal College of Surgeons in 1999. I then spent 3 years completing research into the impact of prostate cancer on the quality of life of men and their partners, and was awarded my MD thesis in 2003. In 2004 I switched to General Practice and am now a partner at Backwell & Nailsea Medical Group in North Somerset. I continue to work in Urology, providing a primary care diagnostic urology service to 3 CCGs, including a community based LUTS, Haematuria and raised PSA one-stop service. I was a member of the Guideline Development Group for the NICE 'Lower Urinary Tract Symptoms in men' Clinical Guideline, published in 2010. I am deputy editor of ‘Trends in Urology and Men’s Health’ and involved extensively in educating my fellow GPs about Urology, particularly through the Prostate Cancer UK Masterclasses. I am currently chair of the educational advisory group for Prostate Cancer UK.

In my ‘spare time’, I am a trustee of the Health Improvement Project Zanzibar– a small UK based charity which runs 2 district hospitals on the island of Zanzibar, providing essential healthcare for over 250,000 people.



Miss Jyoti Shah BSc (Hons) MBBS MRCS MD MS DHMSA FRCS (Urol)

I am a Consultant Urological Surgeon at University Hospitals of Derby and Burton, NHS Foundation Trust in the Midlands where I have a specialist interest in general urology, prostate cancer, innovative techniques and teaching. I established a unique one-stop PSA clinic, undertake prostate biopsies, perform a one-stop haematuria clinic as well as general urology clinics.

I am a passionate campaigner for health & wellbeing within communities and on equality. My campaign Inspire Health: Fighting Prostate Cancer screening has been going into the local communities to bring about awareness of prostate cancer. With the support of Burton Albion Football Club and Burton Albion Community Trust, the campaign has been doing prostate cancer screening at the Pirelli Stadium as well as diversifying further afield with the Rotary Clubs Freemasons and African Caribbean Community.

I was Commissioning Editor for The Annals and Bulletin of the Royal College of Surgeons of England (RCS) 2015 – 2018. Previously I held the Associate Editor role. Iwas the Editor in Chief of Medical Woman (2015 -2017|). My major accolade with the editorship was to produce a souvenir edition of Medical Woman that pulls together some of the brightest and respected female doctors in the profession.

I review for 12 International journals and regularly write peer-reviewed articles. I have published extensively with 63 peer-reviewed publications in International journals, 9 Book chapters, and have authored four books. My recent release ‘How to get your paper published’ co-edited with Pippa Smart was originally a series run by the Royal College of Surgeons  (RCS) Annals publications. I am on the training faculty of the RCS.

My series of articles for the RCS explored the role of  leadership and how the NHS can benefit by learning from the best in professions outside the medical field. My work with the RCS and Medical Woman has allowed me to interview prominent individuals including Amanda Wakeley OBE, Fashion Designer; Sir Clive Woodward, Rugby Union Coach and World Cup Winner; Tess Gerritsen, international best-selling novelist and physician; Niall Dickson, CEO of General Medical Council; Admiral Sir Trevor Soar, former Commander in Chief of the Royal Navy and Vijaya Nath, a leadership specialist with the Leadership Foundation and formerly with the Kings Fund.

Having graduated from Charing Cross Hospital, I completed my postgraduate urological training in London before working as a Locum Urological Surgeon at Kingston Hospital and St. George’s Hospital. I was appointed a substantive consultant in 2008 at Burton Hospital.

I have undertaken a Postgraduate Diploma in Medical Education and am a GMC accredited educational supervisor. I am an educational supervisor to an FY1 at Burton Hospital. I am a Postgraduate tutor for simulation and an examiner for final MBBS at Leicester Medical School (2015-2018). I am an assessor for the Royal College of Surgeons and travel around the country as college representative at urology consultant interviews. I have been invited by University of the West Indies to teach students on current medical practices.



Dr Ann Williams RGN, MSc, MBBS, MRCGP

I began my nurse training in 1982 at the Whittington Hospital now part of UCL. I qualified in 1985 and worked as a Sister on an acute male surgical ward and a urology ward. I moved to Essex in 1993 and worked at Colchester General starting as a Nurse Practitioner in Urology in 1995 and completed a MSc in Advanced Nursing at Essex University. My dissertation was published in the British Journal of Urology. I and my colleague were founder members of BAUN (British Association of Urological Nurses). We also set up many nurse-led clinics and taught other specialist nurses. I started as a Nurse Practitioner in Primary Care in 2002 and, after completing the course, I also qualified as a nurse prescriber.

In 2004 I began my medical training at Barts and The Royal London post graduate training. I continued to work as a nurse during the holidays in out of hours and as a Forensic Medical Examiner for Essex Police. I qualified in 2008 and began my Foundation Training at Broomfield Hospital, Chelmsford. I qualified as a GP in 2013 and now work as a GP Partner at Little Waltham Surgery, Chelmsford. I have always maintained a keen interest in Urology advising the local CCG and triaging urological referrals, dealing with urological patients in primary care, supporting charities, teaching in the local GP Training scheme and for charities.